Sphks as modifiers of the p53 pathway and methods of use

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/48 (2006.01) C12Q 1/02 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2454514

Human SPHK genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of SPHK are provided.

L'invention concerne des gènes humains de la sphingosine kinase (SPHK) qui sont identifiés en tant que modulateurs de la voie de passage p53, et qui sont donc des cibles thérapeutiques destinées à des troubles liés à une fonction p53 déficiente. Cette invention a aussi trait à des méthodes d'identification des modulateurs de p53 consistant à cribler des agents qui modulent l'activité de SPHK.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sphks as modifiers of the p53 pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sphks as modifiers of the p53 pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sphks as modifiers of the p53 pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2058469

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.